Best Life Sciences Companies in Brussels, Belgium
The 35 best Life Sciences companies in Brussels, Belgium in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Precirix.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Brussels
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Precirix Developer of radiopharmaceuticals for treating cancer | $131M | 54 mo ago | Series B | Ruth Devenyns CEO | 2014 | Craft CMSPHPYii+11 | 31 patents Pre-targeted cancer radioimmunotherapy using FAP-specific antibody fragments | — |
| 2 | Noho System to monitor lymphedema care | $18M | 111 mo ago | Deadpooled | Victor Matia Co-Founder | 2015 | — | — | — |
| 3 | Axiles Bionics Provider of ankle-foot prosthesis for specially abled people | $12M | 14 mo ago | Series A | — | 2018 | WebflowAmazon Web Servicescore-js+14 | 24 patents Patents concentrated in health & consumer products | — |
| 4 | Ovizio Developer of an imaging system for microscopes | $9M | 110 mo ago | Series A | — | 2009 | — | — | — |
| 5 | Kaspard Provider of wearable elderly monitoring and fall detection devices | $5M | 62 mo ago | Series A | Philippe Kaplan Founder & CEO | 2017 | HubSpot CMS HubYouTubeHubSpot+11 | — | — |
| 6 | InSilico Genomics Bioinformatics solution for genomic data analysis | $2M | 162 mo ago | Deadpooled | David Y. Weiss Solís Co-Founder & CEO | 2012 | — | — | — |
| 7 | Abscint Developer of radiolabelled single domain antibodies to diagnose cancer and cardiac diseases | $1M | 45 mo ago | Seed | Karine Clauwaert CEO | 2020 | — | — | — |
| 8 | BioSenic Developer of therapeutics for autoimmune and inflammatory diseases | $541K | 31 mo ago | Public | Francois Rieger CEO | 2006 | DrupalPHPBootstrap+8 | 2 patents Mesenchymal stem cell differentiation protocols for regenerative medicine | — |
| 9 | iDklic Digital marketing solution for pharmacies to improve revenue and create Omnichannel communication | $394K | 146 mo ago | Acquired | Jean-Charles Figoni Co-Founder & CEO | 2006 | — | — | — |
Top 12 Life Sciences companies in Brussels
#1
Series A · Brussels, Brussels · founded 2018 · 10 employees$12Mraised▾
Provider of ankle-foot prosthesis for specially abled people
- Jun 2025Series A$6.9M
- 2022Grant (prize money)$5.1M
#2
Series B · Brussels, Brussels · founded 2014 · 22 employees$131.1Mraised▾
Developer of radiopharmaceuticals for treating cancer. The company uses camelid single-domain antibody fragments to develop radioligand therapies for multiple targets. The lead product CAM-H2 targets metastatic HER2-positive cancer.
- Mar 2022Series B$87.8M
- Nov 2018Series A$41.8M
- Seed$1.5M
#3
Public · Brussels, Brussels · founded 2006 · 33 employees$541.3Kraised▾
Developer of therapeutics for autoimmune and inflammatory diseases. The company offer an arsenic trioxide-based treatment and cell therapy platform to address immunity, autoimmune diseases and organ repair.
- Feb 2024Post IPO$541.3K
- Dec 2023Post IPO—
#4
Series A · Brussels, Brussels · founded 2017 · 2 employees$4.8Mraised▾
Kaspard has developed a sensor-based device and platform for monitoring the elderly. The company has developed solutions such as a sensor attached to the wall opposite the bed, an app for monitoring the elderly via pictograms and color codes, and a platform to provide the activity reports at end of the day. The sensor detects in case of a fall or when the patient does not return to bed and sends an alert to the nursing staff. The solutions enable the nurses to continuously monitor and manage care for the elderly in bed exits or provide emergency care.
- Jul 2021Series A$3.7M
- 2019Conventional Debt—
- Mar 2019Seed$1.1M
- Feb 2018Conventional Debt$123.6K
#5
Deadpooled · Brussels, Brussels · founded 2015 · 2 employees$17.8Mraised▾
Noho is a system for keeping track of pressure to be applied for lymphedema patients. Consists of a bandage with sensors to measure the pressure applied. The app collects the data and uploads to a global management platform. This data is then compared with the optimum pressure gradient that should be applied in order to reduce the lymphedema.
- Jun 2017Series A$17.8M
#6
Series A · Brussels, Brussels · founded 2009 · 16 employees$9.3Mraised▾
Developer of an imaging system for microscopes. The company has developed machine-learning software and microscopes. It has developed an AI-based software called OsOne which can provide the 3D analysis of images and continuous data recording among others. Its microscopic products are iLine F, QMode, I Line engineering platform among others.
- Jun 2017Grant (prize money)$57K
- Jan 2017Grant (prize money)$57.1K
- Jan 2016Grant (prize money)$728.7K
- Nov 2015Series A$9.1M
#7
Seed · Ganshoren, Brussels · founded 2020 · 2 employees$1.1Mraised▾
Developer of radiolabelled single domain antibodies to diagnose cancer and cardiac diseases. The company offers ABSCINT-HER2 for the detection of HER2 positive cells in the brains and ABSCINT-206 for the detection of immune cells in granuloma CD-206 positive macrophages in the heart.
- Dec 2022Seed$1.1M
#8
Deadpooled · Brussels, Brussels · founded 2012$1.6Mraised▾
Insilico DB is an online platform for genomic data analysis. It can be used for genomic sample analysis, analysis of samples from public repositories, data storage, data sharing and it also provides access to various analysis tools including GENEE, Morpheus, GenePattern, GenomeSpace, Integrative Genomics Viewer, R/Bioconductor and Ingenuity Pathways Analysis. Insilico has over 2.5 lakh genomic samples from public repositories which can be analysed along with private data. The platform provides access to analysis tool and performs the computing. the collaborative platform helps selectively share data.
- Mar 2013Seed$1.5M
- Nov 2012Angel$80K
#9
Acquired · Brussels, Brussels · founded 2006 · 9 employees$393.7Kraised▾
iDklic is a provider of digital marketing solutions for pharmacies to improve revenue and create Omnichannel communication. The company aids by providing advertisements and screens in pharmacies for patient interaction. The users can customize the content to be displayed according to their needs.
- Jul 2014Grant (prize money)$393.7K
#10
Deadpooled · Brussels, Brussels · founded 2014 · 3 employees$55.1Kraised▾
AuXin Surgery develops medical devices in the field of separation surgeries such as tumor removal and organ separation. The devices are claimed to be proven to facilitate surgical procedure and reduce side effects in multiple indications. The company is expected to submit medical devices for the CE mark and expects to launch it by the end of 2017. The company targets markets such as US, EU, Canada, Australia and Brazil.
- Dec 2019Grant (prize money)$55.1K
- 2016Seed—
- 2015Seed—
#11
Seed · Brussels, Brussels · founded 2016 · 37 employees—raised▾
Spentys designs and develops orthopedic immobilization support devices using 3D printing technology. The personalized orthopedic immobilization devices are 3D based on the patient details and are used for orthopedic rehabilitation.
- Mar 2020Seed—
- Seed—
#12
Deadpooled · Brussels, Brussels · founded 2004—raised▾
Medical Device Works develops medical devices for cancer chemotherapy administration. Its catheter based PILP system is applied percutaneously and allows temporarily isolation of an organ from the body's blood supply by controlling the blood inflow and outflow. This allows chemotherapy to be administered at high concentrations to the affected organ. The drug remains only in the affected organ during the chemotherapy procedure and is afterwards eliminated. Side effects in other parts of the body are thus decreased. Its PILP system is especially marketed for solid organ cancers i.e Liver, Lung, Pancreas etc.. cancer chemotherapy administration
- 2015Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Belgium
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 357 Belgium-affiliated papers.
- KU Leuven58
- Ghent University57
- Triphase36
- Flanders Marine Institute23
- University of Liège22
- Bioprocess3
- Cell biology3
- Mutant3
- Molecular biology3
- Immune system3
- Population1→5
- Antibiotics1→4
- Gene2→4
- Probiotic5
- Food science5
- Population5
- Agriculture5
- Antimicrobial4
Where biotechnology is researched across Belgium
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.